A case of Henoch-Schonlein Purpura with dilated coronary arteries.

Authors:
Jessica L Bloom
Jessica L Bloom
University of Colorado
Jeffrey R Darst
Jeffrey R Darst
The Heart Institute
Lori Prok
Lori Prok
University of Colorado
United States
Jennifer B Soep
Jennifer B Soep
The Children's Hospital
United States

Pediatr Rheumatol Online J 2018 Sep 4;16(1):54. Epub 2018 Sep 4.

Department of Pediatric Rheumatology, Children's Hospital Colorado, 13123 East 16th Avenue, B311, Aurora, CO, 80045, USA.

Background: Henoch-Schonlein Purpura (HSP) is one of the most common vasculitides of childhood, with 10-20 cases per 100,000 children. It frequently occurs following an infectious trigger and involves IgA and C3 deposition in small vessel walls. HSP is characterized by palpable purpura plus IgA deposition on biopsy, arthritis/arthralgia, renal involvement (hematuria and/or proteinuria), and/or abdominal pain. It is not generally recognized as a cause of dilated coronary arteries.

Case Presentation: We describe the first reported case of HSP presenting with dilated coronary arteries. This patient is a nine-year-old previously healthy Caucasian male who presented with 1 week of petechiae on his lower legs, knee and ankle arthritis, and abdominal pain without fever, consistent with HSP. An echocardiogram revealed coronary dilation, including the left main (5.32 mm, Z score + 4.25) and left anterior descending (LAD) (3.51 mm, Z score + 2.64) coronary arteries. He received high dose aspirin, IVIG, and infliximab with normalization of the LAD. Skin biopsy revealed leukocytoclastic vasculitis with positive IgA staining. He was Rhinovirus/Enterovirus positive with Group A Streptococcus on throat culture.

Conclusion: Cardiac findings, while rare, can exist in HSP. Coronary dilation appeared to respond to our hospital protocol's Kawasaki Disease (KD) therapy, possibly indicating an overlap in HSP and KD pathophysiology. This case, along with prior reports of dilated coronaries in systemic juvenile idiopathic arthritis (SJIA), highlights the importance of considering other sources of systemic inflammation, in addition to KD, when coronary dilation is identified. The appropriate therapy, follow-up, and prognosis for our patient are not clear, as further studies are needed to determine the natural course of these findings.

Download full-text PDF

Source
https://ped-rheum.biomedcentral.com/articles/10.1186/s12969-
Publisher Site
http://dx.doi.org/10.1186/s12969-018-0270-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6123917PMC
September 2018
28 Reads

Publication Analysis

Top Keywords

dilated coronary
12
coronary dilation
12
coronary arteries
12
iga deposition
8
henoch-schonlein purpura
8
abdominal pain
8
coronary
7
hsp
6
aspirin ivig
4
ivig infliximab
4
infliximab normalization
4
positive group
4
dose aspirin
4
high dose
4
score + 264 coronary
4
arteries received
4
group streptococcus
4
received high
4
normalization lad
4
lad skin
4

Altmetric Statistics

References

(Supplied by CrossRef)

RE Petty et al.
2016
Article in Arch Dis Child Educ Pract
EJ Tizard et al.
Arch Dis Child Educ Pract 2008
Article in Lancet
FT Saulsbury et al.
Lancet 2007
Article in Ann Rheum Dis
S Ozen et al.
Ann Rheum Dis 2005
Article in Pediatr Radiol
M Soliman et al.
Pediatr Radiol 2015
Article in J Korean Med Sci
Y Kang et al.
J Korean Med Sci 2014
Article in J Am Soc Nephrol
E Pillebout et al.
J Am Soc Nephrol 2002
Article in Am Heart J
D Kereiakes et al.
Am Heart J 1984
Article in Nephrol Dial Transplant
P Carmichael et al.
Nephrol Dial Transplant 2002
Article in Kokyu To Junkan
M Satoh et al.
Kokyu To Junkan 1991
Article in Am J Kidney Dis
M Agraharkar et al.
Am J Kidney Dis 2000

Similar Publications